Kerun Biology

China
Dahu, Fujian, China, 401121

Company profile

Kerun Biology company profile

Chongqing Kerun Biomedical R&D Co., Ltd. was established in 1997, formerly known as Chongqing Rainwater Group Duotai Biomedical Research Institute, focusing on the research and development of recombinant protein drugs. After nearly two decades of development, the company has established a mature yeast expression technology platform and E. coli expression technology platform, and is currently actively building a mammalian cell expression platform. A drug development system with specifications from options, upstream construction, protein expression, process development, quality control, and registration declarations.

Business identity

Contact email
[email protected]
Phone number
023-68603657
Operating status
Active
Company type
For Profit
Founded
1997-01-01, Year

Headquarters

Postal code
401121
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Last funding
Series A / 2024-03-05
Last equity funding
Series A
Investors
1
Lead investors
1

Founders and investors

Lead investors

Zhirui Investment

Investors

Zhirui Investment